Plasma-seq: a novel strategy for metastatic prostate cancer analysis

Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA p...

Descripción completa

Detalles Bibliográficos
Autores principales: Farris, Caitlin, Trimarchi, Jeffrey M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706850/
https://www.ncbi.nlm.nih.gov/pubmed/23673197
http://dx.doi.org/10.1186/gm439
_version_ 1782276418841870336
author Farris, Caitlin
Trimarchi, Jeffrey M
author_facet Farris, Caitlin
Trimarchi, Jeffrey M
author_sort Farris, Caitlin
collection PubMed
description Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA present in the peripheral blood of patients with cancer. The power of this technique is demonstrated with the examination of tumor genomes from patients with prostate cancer. See related research article: http://genomemedicine.com/content/5/4/30
format Online
Article
Text
id pubmed-3706850
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37068502013-07-15 Plasma-seq: a novel strategy for metastatic prostate cancer analysis Farris, Caitlin Trimarchi, Jeffrey M Genome Med Research Highlight Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA present in the peripheral blood of patients with cancer. The power of this technique is demonstrated with the examination of tumor genomes from patients with prostate cancer. See related research article: http://genomemedicine.com/content/5/4/30 BioMed Central 2013-04-29 /pmc/articles/PMC3706850/ /pubmed/23673197 http://dx.doi.org/10.1186/gm439 Text en Copyright © 2013 BioMed Central Ltd
spellingShingle Research Highlight
Farris, Caitlin
Trimarchi, Jeffrey M
Plasma-seq: a novel strategy for metastatic prostate cancer analysis
title Plasma-seq: a novel strategy for metastatic prostate cancer analysis
title_full Plasma-seq: a novel strategy for metastatic prostate cancer analysis
title_fullStr Plasma-seq: a novel strategy for metastatic prostate cancer analysis
title_full_unstemmed Plasma-seq: a novel strategy for metastatic prostate cancer analysis
title_short Plasma-seq: a novel strategy for metastatic prostate cancer analysis
title_sort plasma-seq: a novel strategy for metastatic prostate cancer analysis
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706850/
https://www.ncbi.nlm.nih.gov/pubmed/23673197
http://dx.doi.org/10.1186/gm439
work_keys_str_mv AT farriscaitlin plasmaseqanovelstrategyformetastaticprostatecanceranalysis
AT trimarchijeffreym plasmaseqanovelstrategyformetastaticprostatecanceranalysis

Ejemplares similares